US Bill Recap: What Are The Latest Legislation Moves Covering Generics And Biosimilars?

The US Congress Halls Have Been Buzzing With New Developments In September

 
• By Urtė Fultinavičiūtė

Generics Bulletin reviews several critical US bills and the off-patent industry’s response, along with budget calculations and new proposals.

US flag in front of the Capitol Hill
• Source: Shutterstock

More from Regulation

More from Policy & Regulation